Needle-Free Injection System Market Increasing incidence of communicable diseases due to needlestick injuries expected to CAGR of 15.5% By 2030

Pune, India, October 2022/MRFR Press Release/- Market Research Future has published its half-cooked research report on the global needle-free injection system market.

Market Highlights

According to MRFR analysis, the global needle-free injection system market is expected to register a CAGR of 15.5% from 2022 to 2030 and hold a value of over USD 422.20 million by 2030.

The global needle-free injection system market is driven by several factors, such as the increasing incidence of communicable diseases due to needlestick injuries, the increase in the population suffering from diabetes, and the rise in demand for self-injection devices. For instance, according to the National Institute of Allergy and Infectious diseases (NIAID), Annually infectious diseases claim more than 15 million lives globally. Similarly. As per WHO 2021 data, there were an estimated 37.3 million people living with HIV at the end of 2020. Over two-thirds of whom 25.4 million are in the WHO African region. Moreover, rising demand for biosimilars and vaccination processes is anticipated to drive market growth further.

Additionally, the COVID-19 pandemic significantly increased the demand for needle-free injection system devices. Companies are increasingly focusing on developing needle-free injection systems to meet the increased demand and specific needs. For instance, In January 2019, Enesi Pharma Limited (UK) and GeoVax (US) formed a partnership to develop next-generation needle-free, thermostable vaccinations for a variety of infectious diseases. Hence, the pandemic had a positive impact on market growth.

Access full report @ https://www.marketresearchfuture.com/reports/needle-free-injection-system-market-11234

Regional Analysis

North America is likely to dominate the needle-free injection system market presence of highly developed healthcare infrastructure, high patient awareness levels, increasing cases of chronic illnesses, and high research and development in needle-free injection technology in the region.

Europe is likely to account for a significant share in the needle-free injection system market due to increased chronic illness occurrences due to lifestyle changes, an aging population, demand for home-based monitoring devices, and needle-free injection devices’ simplicity of use and portability. For instance, researchers in the Netherlands are developing laser technology to enable "virtually painless" injections without needles in what they call a breakthrough that will ease fear and lower the threshold for vaccinations.

Asia-Pacific is projected to be the fastest-growing regional market during the forecast period owing to the increase in disposable income and growth in public healthcare funding in major emerging economies like China and India. The increase in the rate of adoption of needle-free injectors for vaccination purposes is another major factor for the rapid growth in the region during the forecast period. Furthermore, global key players' initiatives to expand operations in the region are also boosting market growth.

The market's growth in the Rest of the World is slower than in the other regions due to Low awareness levels of needle-free injection systems and poor rules and regulations regarding medical waste management and low safety standards in these regions. However, government initiatives to develop the healthcare infrastructure and bring in new technologies are expected to drive market growth.

Segmentation

The global needle-free injection system market has been segmented into product, type, technology, site of delivery, usability, application, and end users.

Based on product, the market has been segmented into prefilled needle-free injectors and fillable needle-free injectors. The fillable needle-free injectors held a higher share in 2021 due to the increasing application of needle-free injections in vaccination, insulin, and other drug delivery.

Based on type, the market has been segmented into liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors. The liquid-based injectors segment held a higher share in 2021 due to the ability of a liquid jet, which is stronger enough to penetrate the skin and the underlying fat layer without harming the skin or the integrity of the drug molecule.

Based on technology, the market has been segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment held a larger share of the market in 2021 attributed to benefits associated with this technology, including rapid drug administration, improved dosage accuracy, better diffusion into the tissue, and a faster response rate.

Based on the site of delivery, the market has been segmented into intra-dermal injectors, intramuscular injectors, and subcutaneous injectors. The subcutaneous injectors segment held a larger share in the market in 2021 due to its greater effectiveness as the drug moves into the capillaries when it is injected and from there, it is carried to the bloodstream.

Based on usability, the market has been segmented into Disposable needle-free injectors and Reusable needle-free injectors. The reusable needle-free injectors segment held a larger share of the market in 2021. This is due to, as they are cost-effective in the long run, with only the vial requiring regular purchase and increasing adoption of reusable needle-free injections.

Based on application, the market has been segmented into vaccine delivery, insulin delivery, pain management, and others. The vaccine delivery segment held a larger share in the market in 2021, owing to the rising prevalence of chronic diseases and infectious diseases worldwide and the rising demand for patient-centric care.

Based on end user, the market has been segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others. The hospitals and clinics segment held a larger share in 2021 due to an increase in hospital admissions and the availability of cutting-edge medical treatments in private hospitals, the sector of hospitals has experienced tremendous growth in recent years.

Key Players

Some of the key market players are Medical International Technology (MIT) (US), and Pharma Jet.(US), Antares Pharma. (US), Endo International (US), Ferring B.V. (Switzerland), Bioject Medical Technologies (US), NuGen Medical Devices (Canada), Portal Instruments (US), Enesi Pharma Limited (UK), and Crossject (France).